Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Multiple myeloma advances for the future suggested by phase I clinical research

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Multiple myeloma advances for the future suggested by phase I clinical research ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Advances in myeloid disease from ASH 2012 from the Sarah Cannon Research Institute

Dr Michael Savona - Sarah Cannon Research Institute, Nashville, USA
Advances in myeloid disease from ASH 2012 from the Sarah Cannon Research Institute ( Dr Michael Savona - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Investigation of Ki67 biomarker

Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada
Investigation of Ki67 biomarker ( Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada )
17 Dec 2012

A need for clarity in clinical trial end points

Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA
A need for clarity in clinical trial end points ( Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA )
13 Dec 2012

Expanding international collaboration at IFOM

Prof Marco Foiani – IFOM – University of Milan, Italy
Expanding international collaboration at IFOM ( Prof Marco Foiani – IFOM – University of Milan, Italy )
21 Nov 2012

Perception of inequalities in care and cancer registries

Sir Michael Richards – Department of Health, UK
Perception of inequalities in care and cancer registries ( Sir Michael Richards – Department of Health, UK )
15 Nov 2012

Development of clinical trials and biobanks

Prof Hani Gabra – Imperial College London, UK
Development of clinical trials and biobanks  ( Prof Hani Gabra – Imperial College London, UK )
15 Nov 2012

Participation in clinical trials

Richard Stephens – VNCRI and NCRN Consumer Liaison Groups
Participation in clinical trials ( Richard Stephens – VNCRI and NCRN Consumer Liaison Groups )
14 Nov 2012

A multi-discipline approach to personalised medicine

Prof Vincenzo Valentini – President of ESTRO; Prof Peter Naredi – ESSO, Former President; Prof Paolo Casali – ESMO, Executive Board Member
A multi-discipline approach to personalised medicine ( Prof Vincenzo Valentini – President of ESTRO; Prof Peter Naredi – ESSO, Former President; Prof Paolo Casali – ESMO, Executive Board Member )
22 Oct 2012

Challenges to the development of personalised medicine

Prof Alexander Eggermont – President of the European Academy of Cancer Sciences; Prof Franҫoise Meunier – Director General, EORTC
Challenges to the development of personalised medicine ( Prof Alexander Eggermont – President of the European Academy of Cancer Sciences; Prof Franҫoise Meunier – Director General, EORTC )
22 Oct 2012

Progress of personalised oncology treatment

Prof Martine Piccart – President-Elect of ECCO
Progress of personalised oncology treatment ( Prof Martine Piccart – President-Elect of ECCO )
22 Oct 2012

Role of ECCO in the development of personalised oncology treatment

Kathy Oliver – ECCO Patient Advisory Committee; Prof Julio Celis – ECCO Policy Committee; Prof Cornelis van de Velde – President of ECCO
Role of ECCO in the development of personalised oncology treatment ( Kathy Oliver – ECCO Patient Advisory Committee; Prof Julio Celis – ECCO Policy Committee; Prof Cornelis van de Velde – President of ECCO )
22 Oct 2012